home.social

#phaseii — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #phaseii, aggregated by home.social.

fetched live
  1. SynAct Pharma Completes Recruitment for ADVANCE

    SynAct Pharma has met the recruitment target for its Phase II ADVANCE study of resomelagon. Once the final patient completes the 12-week period and follow-up, database lock will commence at over 30 clinics. The trial evaluates dose-dependent safety and efficacy while maintaining a favorable risk/benefit profile.

    #SynActPharma #biotech #PhaseII #clinicaltrials

  2. SynAct Pharma Completes Recruitment for ADVANCE

    SynAct Pharma has met the recruitment target for its Phase II ADVANCE study of resomelagon. Once the final patient completes the 12-week period and follow-up, database lock will commence at over 30 clinics. The trial evaluates dose-dependent safety and efficacy while maintaining a favorable risk/benefit profile.

    #SynActPharma #biotech #PhaseII #clinicaltrials

  3. NMD Pharma Reports Topline Phase IIa Results

    NMD Pharma announced data from the SYNAPSE-CMT study evaluating ignaseclant in Charcot-Marie-Tooth disease types 1 and 2. The CIC-1 inhibitor showed consistent functional improvements regarding muscle strength, motor performance, and patient-reported outcomes. Ignaseclant targets the skeletal muscle-specific chloride ion channel 1.

    #biotech #CMT #lifescience #PhaseII

  4. NMD Pharma Reports Topline Phase IIa Results

    NMD Pharma announced data from the SYNAPSE-CMT study evaluating ignaseclant in Charcot-Marie-Tooth disease types 1 and 2. The CIC-1 inhibitor showed consistent functional improvements regarding muscle strength, motor performance, and patient-reported outcomes. Ignaseclant targets the skeletal muscle-specific chloride ion channel 1.

    #biotech #CMT #lifescience #PhaseII